Education And Debate
The other face of research governance
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7460.280 (Published 29 July 2004) Cite this as: BMJ 2004;329:280
Related articles
- This Week In The BMJ Published: 29 July 2004; BMJ 329 doi:10.1136/bmj.329.7460.0
- Letter Published: 09 September 2004; BMJ 329 doi:10.1136/bmj.329.7466.622
- LetterResearch bureaucracy in the United Kingdom: Research governance is about protection, not conveniencePublished: 09 September 2004; BMJ 329 doi:10.1136/bmj.329.7466.623-b
- News Extra [these Stories Appear Only On The Web] Published: 25 November 2004; BMJ 329 doi:10.1136/bmj.329.7477.1258-f
- Letter Published: 29 July 2004; BMJ 329 doi:10.1136/bmj.329.7460.294
- Primary Care Published: 20 October 2005; BMJ 331 doi:10.1136/bmj.38583.625613.AE
- PRIMARY CARE Published: 12 September 2005; BMJ doi:10.1136/bmj.38583.625613.AE
- Letter Published: 09 September 2004; BMJ 329 doi:10.1136/bmj.329.7466.623-a
- Letter Published: 29 July 2004; BMJ 329 doi:10.1136/bmj.329.7460.294-a
- Letter Published: 09 September 2004; BMJ 329 doi:10.1136/bmj.329.7466.623-c
See more
- Trump chooses Obamacare opponent to lead Health and Human ServicesBMJ November 30, 2016, 355 i6469; DOI: https://doi.org/10.1136/bmj.i6469
- Drug firms need to tackle affordabilityBMJ November 14, 2016, 355 i6096; DOI: https://doi.org/10.1136/bmj.i6096
- World Medical Association’s tainted president, Ketan DesaiBMJ November 10, 2016, 355 i5867; DOI: https://doi.org/10.1136/bmj.i5867
- Cancer drugs, survival, and ethicsBMJ November 09, 2016, 355 i5792; DOI: https://doi.org/10.1136/bmj.i5792
- WHO refers $29m Oxford research project to GMC for misconductBMJ November 07, 2016, 355 i5971; DOI: https://doi.org/10.1136/bmj.i5971
Cited by...
- Do research ethics committees identify process errors in applications for ethical approval?
- BMFMS: Pregnancy Outcome
- Status of healthcare studies submitted to UK research ethics committees for approval in 2004-5
- Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies
- Research bureaucracy in the United Kingdom: Seeking a balance: response from the Department of Health and COREC
- Research bureaucracy in the United Kingdom: Research governance is about protection, not convenience
- Research bureaucracy in the United Kingdom: Good governance is needed
- Research bureaucracy in the United Kingdom: Time has come to face research governance
- View from the research and development office
- Clinical research under the cosh again